Verrica Pharma Shuffles Leadership, Adds Directors
Ticker: VRCA · Form: 8-K · Filed: Sep 6, 2024 · CIK: 1660334
| Field | Detail |
|---|---|
| Company | Verrica Pharmaceuticals Inc. (VRCA) |
| Form Type | 8-K |
| Filed Date | Sep 6, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, board-of-directors, executive-compensation
TL;DR
Verrica Pharma's CMO is out, two new directors are in, and executive pay details are out.
AI Summary
Verrica Pharmaceuticals Inc. announced on August 30, 2024, the departure of its Chief Medical Officer, Dr. Robert W. Buck, effective the same date. The company also reported the election of two new directors, Dr. Paul J. Hastings and Mr. David R. Johnson, to its Board of Directors, effective August 30, 2024. Additionally, the company disclosed compensatory arrangements for certain officers.
Why It Matters
Changes in key leadership and board composition can signal shifts in company strategy or operational focus, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Leadership changes and board refreshes can introduce uncertainty regarding future strategy and execution.
Key Players & Entities
- Verrica Pharmaceuticals Inc. (company) — Registrant
- Dr. Robert W. Buck (person) — Chief Medical Officer who departed
- Dr. Paul J. Hastings (person) — Newly elected Director
- Mr. David R. Johnson (person) — Newly elected Director
- August 30, 2024 (date) — Effective date of departures and appointments
FAQ
Who has departed from Verrica Pharmaceuticals Inc.?
Dr. Robert W. Buck, the Chief Medical Officer, departed from Verrica Pharmaceuticals Inc. effective August 30, 2024.
When was Dr. Robert W. Buck's departure effective?
Dr. Robert W. Buck's departure was effective August 30, 2024.
Who were elected as new directors to Verrica Pharmaceuticals Inc.'s Board?
Dr. Paul J. Hastings and Mr. David R. Johnson were elected as new directors to Verrica Pharmaceuticals Inc.'s Board.
When were the new directors elected?
The new directors, Dr. Paul J. Hastings and Mr. David R. Johnson, were elected effective August 30, 2024.
What other information is disclosed in this 8-K filing?
The filing also discloses compensatory arrangements of certain officers.
Filing Stats: 516 words · 2 min read · ~2 pages · Grade level 12.1 · Accepted 2024-09-06 16:16:31
Filing Documents
- d894672d8k.htm (8-K) — 23KB
- 0001193125-24-215180.txt ( ) — 141KB
- vrca-20240830.xsd (EX-101.SCH) — 3KB
- vrca-20240830_lab.xml (EX-101.LAB) — 18KB
- vrca-20240830_pre.xml (EX-101.PRE) — 11KB
- d894672d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Verrica Pharmaceuticals Inc. Date: September 6, 2024 /s/ P. Terence Kohler Jr. P. Terence Kohler Jr. Chief Financial Officer